Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare Conference

PUBT · 1d ago
Merck CEO Davis, R&D head Li to speak at Morgan Stanley Global Healthcare Conference
  • Merck will join Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.
  • CEO Robert M. Davis will take part in a fireside chat at 3:20 p.m. ET.
  • Merck Research Laboratories head Dean Y. Li will also participate in the session.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260908391410) on September 08, 2026, and is solely responsible for the information contained therein.